项目方案

Guangdong Tianpu Biochemical Pharmaceutical Co., Ltd

发布时间 : 2025-04-02

Focus on sprinting towards FDA and entering the global market with a high starting point

Guangdong Tianpu Biochemical Pharmaceutical Co., Ltd. was established in 1993, headquartered in the core area of Guangzhou's eastern smart city, covering an area of 50000 square meters, focusing on the development, production, and sales of drugs in the critical care field. The company adheres to the core values of "integrity and honesty; passion and perseverance; commitment and efficiency; care and participation; innovation and learning; cooperation and communication", and has the national second-class new drug (exclusive domestic variety) Tianploan ® (Ulastatin for injection), the world's first new drug Kailikang ® (Urine for injection).


天普.jpg


Challenges/initial situation


On February 25, 2025, Guangdong Tianpu Biochemical Pharmaceutical Co., Ltd. was established, which has developed a complete set of protein separation and purification technologies with independent intellectual property rights and obtained two core technology invention patents.

January 23, 2025 · Urokinase (Techpool Bio Pharma): an enzyme replacement drug, first developed by Techpool Bio Pharma Co., Ltd. (Guangdong Techpool Bio Pharma Co., Ltd.), currently with the highest research and development status approved for market worldwide. It is a national second-class new drug, Techpool Bio Pharma ® The launch of Ulastatin for injection has filled a domestic gap and made China the second country in the world to possess the drug.

天普2.png

Solution/portfolio

 

The continuous monitoring system of Borong Environment adopts a wireless combined with wired architecture for implementation and stable operation.

With unique transmission stability and data redundancy, it ensures data integrity in catastrophic situations, scalable architecture, and excellent system performance, providing a strong foundation for cost reduction, efficiency improvement, stable operation, and convenient and rapid implementation of later supplementary monitoring point construction, installation, and verification. Customers can efficiently provide support when facing quality audits such as those conducted by the European Union.


返回列表

Copyright©2019Qingdao Borong IoT Technology Co., Ltd All right reserved    鲁ICP备20030433号-1    鲁公网安备 000000号   网站地图

技术支持:青岛新视点

0.088180s